Clinical Trials Directory

Trials / Sponsors / Changzhou No.2 People's Hospital

Changzhou No.2 People's Hospital

Academic / Other · 10 registered clinical trials — 7 currently recruiting.

StatusTrialPhaseStarted
Not Yet RecruitingUCAR T-cell Therapy Targeting CD19/ BCMA in Patients With Relapse/ Refractory Autoimmune Diseases
Systemic Lupus Erythematosus, Autoimmune Hemolytic Anemia, Myasthenia Gravis
Phase 12025-05-01
RecruitingAn Clinical Study of CD19 CAR NK Cells for the Treatment of Refractory Primary Immune Thrombocytopenia
Thrombocytopenia Alloimmune
EARLY_Phase 12024-08-30
Recruitingγδ T-PD-1 Ab Cells in the Treatment of Advanced Solid Tumors
Advanced Solid Tumor
Phase 12024-08-01
RecruitingFMT+SOX+Sintilimab As First-line Treatment for Advanced Gastric Cancer
Gastric Cancer
Phase 22024-06-01
RecruitingFMT+Immunotherapy+Chemotherapy As First-line Treatment for Driver-gene Negative Advanced NSCLC
Non-small Cell Lung Cancer
Phase 22024-06-01
Not Yet RecruitingAn Clinical Study of NKG2D-CAR-NK Cells for the Treatment of Refractory Recurrent Multiple Myeloma
Multiple Myeloma
EARLY_Phase 12024-04-18
RecruitingEffectiveness of Multimedia Health Education to Reduce Anxiety in Patients With Vitreous Floaters
Vitreous Floaters, Anxiety
N/A2023-12-01
CompletedEffectiveness and Safety of 25-Gauge Needle-Assisted Phacoemulsification of Dislocated Intravitreal Lens Nucle
Dislocated Lens, Pars Plana Vitrectomy, Phacoemulsification
—2022-07-01
UnknownApatinib Combined With S-1 in the Second-line Treatment of Advanced Pancreatic Cancer
Advanced Pancreatic Cancer
Phase 22018-09-15
UnknownPhase II Trial of Thalidomide Combined With Concurrent Chemoradiotherapy in Esophageal Cancer
Esophageal Cancer
Phase 22012-01-01